Access cutting-edge brain cancer treatment through this clinical trial at a research site in Manhasset. Study-provided care at no cost to qualified participants.
Access brain cancer specialists in Manhasset at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain cancer treatment provided free
This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced delivery to patients with recurrent or progressive malignant glioma after standard surgical, radiation, and/or chemotherapy treatment. The study uses a modified Fibonacci dose escalation, followed by an expansion at the maximum tolerated dose (MTD) to determine efficacy. The starting absorbed dose is 1mCi in a volume of 0.660
Sponsor: Plus Therapeutics
Check if you qualify for this brain cancer clinical trial in Manhasset, NY
If you're searching for brain cancer treatment options in Manhasset, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Manhasset research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.